The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction options for adults with moderate to severe active Crohn disease.

An experimental Alzheimer's treatment from Boston researchers may be able to treat both dementia and depression symptoms.

Exercise, especially strengthening exercise, improved the sleep quality scores of older adults more than normal activity.

An updated guideline has been published by the AHA, ACC, and other organizations regarding the management of acute coronary syndrome.

Pulmonary rehabilitation significantly improves physical capacity, lung function, and quality of life in long COVID patients, with the greatest benefits seen in 4-8 week programs combining breathing ...